在住院养老机构中成功进行药物审查和停止处方干预措施的特点:更新系统审查的干预组件分析
在PubMed上查看摘要
概括
此摘要是机器生成的。在老年护理机构的药物检查和减缓处方可以减少跌倒. 成功的关键特征包括临床医师的工具,定期的检查,以及涉及通常的护理处方者. 这样可以优化药物使用并防止跌倒.
科学领域
- 老年学
- 药理学
- 临床试验
背景情况
- 在居住老人护理设施 (RACF) 中,跌倒是很大的风险.
- 药物审查和减缓处方是针对可修改的风险因素,如高风险药物和多种药物的已确立预防策略.
- 试验结果的变化需要了解关键的干预组件.
研究的目的
- 确定有助于成功或失败的关键干预组件药物审查和降低在RACF预防的试验.
- 从试验者的角度来看,开发一个解释为什么某些药物审查/处方干预措施会减少跌倒,而其他干预措施则不会的理论.
主要方法
- 使用已发表的随机对照试验 (RCT) 讨论部分的诱导主题分析进行了干预组件分析 (ICA).
- 包括通过Cochrane审查和补充搜索到2025年4月的RACF中评估药物审查/不再处方作为独立的防摔干预措施.
- 检查了确定的主题/子主题与报告的试验结果之间的一致性.
主要成果
- 分析了来自6个国家的13项试验.
- 试验人员确定了必要的组件:一个决策支持工具 (算法/列表),至少一名来自住院常规护理团队的处方师的参与,以及至少每六个月一次的药物审查.
- 这些关键特征存在于所有成功的试验中 (100%),但只有20%的试验失败.
结论
- 干预组件分析表明,临床医生的决策支持工具,定期 (至少每六个月一次) 药物审查以及常规护理处方师的参与对于在RACF中成功进行防摔干预至关重要.
- 这种优化的药物管理方法与当前的世界布指南相一致,并保证在未来的随机对照试验中对RACF居民进行测试.
相关概念视频
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
• Purpose: Documentation in long-term care facilities is critical for interprofessional resident assessment and planning. It ensures that all aspects of a resident's care - from medical needs to daily living assistance - are thoroughly...
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

